MariHashitateDallasMD

Pediatric Hematology & Oncology • Cleveland, OH

Associate Professor, Pediatrics, Case Western Reserve University School of Medicine, Rainbow Babies & Children's Hospital

Join to view full profile

Dr. Dallas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dallas' full profile

Already have an account?

Office
UH Rainbow Babies and Children's Hospital
11100 Euclid Ave Department of Pediatrics-Hematology and Oncology
Cleveland, OH 44106
Phone+1 216-844-3951

Fax+1 216-201-6790

Education & Training

University of WashingtonFellowship, Pediatric Hematology/Oncology, 2002 - 2005
Children's Hospital of PhiladelphiaResidency, Pediatrics, 1999 - 2002
Perelman School of Medicine at the University of PennsylvaniaClass of 1999

Certifications & Licensure

OH State Medical License 2016 - 2025
TN State Medical License 2009 - 2017
WA State Medical License 2002 - 2010
PA State Medical License 2001 - 2002
American Board of Pediatrics Pediatrics

Clinical Trials

Umbilical Cord Blood Transplantation In Patients With Hematologic Malignancies Using A Myeloablative Preparative Regimen Start of enrollment: 2011 Jun 15
Completed
Phase 2
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
Recruiting
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation Start of enrollment: 2012 Feb 01
Recruiting
Phase 2
Combined T Cell Depleted Haploidentical Peripheral Blood Stem Cell and Unrelated Umbilical Cord Blood Transplantation in Patients With Hematologic Malignancies Using a Total Lymphoid Irradiation Based Preparative Regimen Start of enrollment: 2014 Jul 11
Terminated
Phase 2
Antigen Specific Adoptive T Cell Therapy for Adenovirus Infection After Hematopoietic Stem Cell Transplantation Start of enrollment: 2019 Jan 04
Recruiting
Early Phase 1
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant Start of enrollment: 2019 Aug 29
Recruiting
Phase 2
Roles: Contact, Principal Investigator
Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia Start of enrollment: 2024 Jul 31
Not yet recruiting
Not Applicable
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Disease Status and Interval between Hematopoietic Cell Transplantations Predict Outcome of Pediatric Patients Who Undergo Subsequent Transplantation for Relapsed Hemat...
Rebecca Epperly, Ying Li, Subodh Selukar, Emily Zeng, Renee Madden
Transplantation and Cellular Therapy. 2024-05-01
5 citations
Case report: Daratumumab treatment in pre-transplant alloimmunization and severe hemolytic anemia.
Maria A Pereda, Smitha Hosahalli Vasanna, Neha J Desai, Victoria Deng, Amma Owusu-Ansah
Frontiers in Immunology. 2022-01-01
100 citations
Pediatric acute lymphoblastic leukemia, version 2.2020
Patrick A. Brown, Hiroto Inaba, Colleen Annesley, Jill C. Beck, Susan Colace
Journal of the National Comprehensive Cancer Network. 2020-01-01